Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 4 1Phase 1/2 1

Status

Completed 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 2Pancreatic Neoplasms 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Pharmacokinetics × Clear all
NCT05540340 2026-03-06

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
39 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

The Netherlands Cancer Institute

Phase 1 Not yet recruiting
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Memorial Sloan Kettering Cancer Center

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT02120222 2023-04-04

KPT-330

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
8 enrolled
Dermatologic

Melanoma

NCT00323323 2017-01-20

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
24 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡